Cartilage Degeneration Clinical Trial
Official title:
The Assessment of Talar Cartilage, Tibialis Antetior and Gastrocnemius Muscles in Patients With Unilateral Traumatic Transtibial Amputation: a Clinical and Sonographic-controlled Study
NCT number | NCT04486534 |
Other study ID # | 4 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 26, 2020 |
Est. completion date | January 15, 2021 |
Increased risk of osteoarthritis (OA) has been previously demonstrated in patients with lower limb amputation. Although there are many studies on knee joint of intact limb of amputees in the literature, the number of studies on intact foot and ankle is extremely limited. The primary aim of the study is to compare the intact talar cartilage, tibialis anterior and gastrocnemius muscle thickness measurements of traumatic unilateral transtibial amputee patients with that of healthy individuals using ultrasound. The secondary aim is to investigate the relationship between cartilage and muscle thickness measurements with clinical parameters.
Status | Completed |
Enrollment | 72 |
Est. completion date | January 15, 2021 |
Est. primary completion date | January 15, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Patients between the ages of 18-65 - Patients who have been followed up for at least 3 months with the diagnosis of unilateral transtibial amputation - Patients who have been using prostheses for at least 3 months Exclusion Criteria: - Bilateral amputation - Previous history of any trauma/surgical history of the lower extremities (other than amputation) - Rheumatic diseases - Contracture of the knee and the ankle of the intact limb |
Country | Name | City | State |
---|---|---|---|
Turkey | Merve Orucu Atar | Ankara | Cankaya |
Lead Sponsor | Collaborator |
---|---|
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Talar cartilage, tibialis anterior and gastrocnemius muscle thickness measurements | Talar cartilage, tibialis anterior and gastrocnemius muscle thickness measurements will be performed by using ultrasound. | through study completion, an average of one and a half months | |
Secondary | 6-minute walking test | Functional performance will be assessed by 6-minute walking distance (in meter) | through study completion, an average of one and a half months | |
Secondary | The Foot and Ankle Outcome Score (FAOS) | The Foot and Ankle Outcome Score (FAOS) will be used for the assessment of the symptoms and the functional limitations of the foot and ankle. The FAOS consists of 42 questions, divided into five different patient-relevant subscales: pain (nine questions); symptoms such as stiffness, swelling and range of motion (seven questions); activities of daily living (17 questions); ability to perform sports and recreational activities (five questions); and foot/ankle-related quality of life (four questions). Answers are given on a five-point Likert scale. Total and subscores are calculated by summing the scores of the individual items. The total score is recoded into a 0-100 scale, with 100 representing no symptoms or limitations. | through study completion, an average of one and a half months | |
Secondary | Short Form-36 (SF-36) | The health-related quality of life of the subjects will be evaluated with Short Form-36 (SF-36). This comprises 36 questions related to eight different subscales, physical functioning, bodily pain, role limitation, due to physical health problems, general health perceptions, vitality, energy and fatigue, role limitations due to emotional problems, social functioning and general mental health, which covers psychological distress and wellbeing. Each of eight subscales is scored between 0 and 100, with higher scores indicating a better quality of life. | through study completion, an average of one and a half months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Completed |
NCT03850080 -
Autologous Conditioned Serum: Functional and Clinical Results
|
Phase 2/Phase 3 | |
Withdrawn |
NCT03648463 -
Use of MRI Labeling Technique to Track Mesenchymal Stem Cell Survival in Orthopaedic Conditions
|
N/A | |
Recruiting |
NCT03477942 -
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
|
Phase 1 | |
Recruiting |
NCT03955497 -
Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05865899 -
Impact of High Tibial Osteotomy in Preventing Degenerative Disease Progression in Medial Knee Osteoarthritis.
|
N/A | |
Completed |
NCT03072147 -
Teriparatide as a Chondroregenerative Therapy in OA
|
Phase 2 | |
Recruiting |
NCT04310852 -
Knee Osteoarthritis Treatment With Percutaneous Injections of Autologous Bone Marrow Concentrate
|
||
Completed |
NCT04454164 -
Platelet Rich Plasma Injection for Knee Osteoarthritis
|
Early Phase 1 | |
Recruiting |
NCT06368544 -
Effect of Early Gait Training on Knee Cartilage Degeneration After Anterior Cruciate Ligament Reconstruction
|
N/A | |
Recruiting |
NCT03790189 -
Subchondral and Intra-articular Application of Bone Marrow Concentrate for Knee Unicompartmental OA
|
N/A | |
Completed |
NCT01418755 -
Study of Platelet-rich Plasma in Treating Patients With Tibiofemoral Cartilage Degeneration
|
N/A | |
Recruiting |
NCT06249906 -
Efficacy of Bioceramic Materials for Bone Defects Repair
|
N/A | |
Not yet recruiting |
NCT04968665 -
The Mechanism for the Effects of Joint Biomechanical Properties on Medial Cartilage of Tibiofemoral Joint Degeneration
|
||
Recruiting |
NCT04536103 -
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
|